Lilly’s weight-loss drug expected to show heart benefit similar to Wegovy, experts say

Some leading obesity specialists in the US say they expect Eli Lilly’s potent weight-loss drug Zepbound to produce the same or similar cardiac benefits as Novo Nordisk’s popular Wegovy.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM